PT71169A - Process for preparing babesiosis antigen and vaccines and diagnostic reagents containing said antigen - Google Patents

Process for preparing babesiosis antigen and vaccines and diagnostic reagents containing said antigen

Info

Publication number
PT71169A
PT71169A PT71169A PT7116980A PT71169A PT 71169 A PT71169 A PT 71169A PT 71169 A PT71169 A PT 71169A PT 7116980 A PT7116980 A PT 7116980A PT 71169 A PT71169 A PT 71169A
Authority
PT
Portugal
Prior art keywords
antigen
vaccines
preparing
babesiosis
diagnostic reagents
Prior art date
Application number
PT71169A
Other languages
English (en)
Portuguese (pt)
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of PT71169A publication Critical patent/PT71169A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A61K39/018—Babesia antigens, e.g. Theileria antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PT71169A 1979-04-30 1980-04-30 Process for preparing babesiosis antigen and vaccines and diagnostic reagents containing said antigen PT71169A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3466479A 1979-04-30 1979-04-30
US06/130,481 US4596707A (en) 1979-04-30 1980-03-31 Babesia parasite antigen useful in vaccine and diagnostic reagent

Publications (1)

Publication Number Publication Date
PT71169A true PT71169A (en) 1980-05-01

Family

ID=26711229

Family Applications (1)

Application Number Title Priority Date Filing Date
PT71169A PT71169A (en) 1979-04-30 1980-04-30 Process for preparing babesiosis antigen and vaccines and diagnostic reagents containing said antigen

Country Status (8)

Country Link
US (1) US4596707A (Direct)
EP (1) EP0018579B1 (Direct)
AU (1) AU531965B2 (Direct)
DE (1) DE3064090D1 (Direct)
GR (1) GR68201B (Direct)
IE (1) IE49590B1 (Direct)
IL (1) IL59841A (Direct)
PT (1) PT71169A (Direct)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124548A4 (en) * 1982-11-10 1985-04-25 Commw Scient Ind Res Org BABESIOSIS ANTIGEN AND PREPARATION METHOD.
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
FR2589063B1 (fr) * 1985-10-24 1988-08-26 Rhone Merieux Procede de culture de babesia canis, application a la preparation d'antigenes et de vaccins, et antigenes et vaccins contre la piroplasmose
US4721617A (en) * 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
GB8630851D0 (en) * 1986-12-24 1987-02-04 Department Of Agriculture For Babesia divergens antigen & vaccine
US5273884A (en) * 1989-01-25 1993-12-28 Commonwealth Scientific & Industrial Polypetides, antigens or vaccines protective against babesiosis
FR2655853B1 (fr) * 1989-12-20 1994-06-10 Centre Nat Rech Scient Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes.
US5643737A (en) * 1992-06-22 1997-07-01 The United States Of America As Represented By The Secretary Of Agriculture Merozoite proteins for use in detection of Babesia equi in horses using immunological techniques
EP0691131B1 (en) * 1994-06-06 1999-10-06 Akzo Nobel N.V. Babesia vaccine
ES2141297T3 (es) * 1994-06-06 2000-03-16 Akzo Nobel Nv Vacuna contra la babesiosis.
FR2724392B1 (fr) * 1994-09-08 1996-12-13 Virbac Lab Procedes de culture, d'attenuation de la virulence et de clonage in vitro de parasites du genre babesia et leurs applications
US6214971B1 (en) * 1996-10-01 2001-04-10 Corixa Corporation Compounds and methods for the diagnosis and treatment of Babesia microti infection
US6451315B1 (en) 1996-10-01 2002-09-17 Corixa Corporation Compounds and methods for the diagnosis and treatment of B. microti infection
US6569433B1 (en) 1996-10-01 2003-05-27 Corixa Corporation Compounds and methods for the diagnosis and treatment of B. microti infection
US6306396B1 (en) 1996-10-01 2001-10-23 Corixa Corporation Compounds and methods for the diagnosis and treatment of B. microti infection
RU2373954C1 (ru) * 2008-04-28 2009-11-27 Общество с ограниченной ответственностью "ШИ-КОН" Способ приготовления вакцины против кровепаразитарных инфекций
RU2429010C2 (ru) * 2009-10-14 2011-09-20 Государственное научное учреждение Всероссийский научно-исследовательский институт экспериментальной ветеринарии им. Я.Р. Коваленко (ВИЭВ) Способ получения высокоактивных и высокоспецифичных антигенов для диагностики бабезиоза собак в серологических реакциях
CN106978425B (zh) * 2017-02-17 2019-10-18 华中农业大学 东方巴贝斯虫1-脱氧-d-木酮糖-5-磷酸还原异构酶基因及其编码的蛋白
EP4061410A4 (en) * 2019-11-21 2024-05-22 Griffith University IMMUNOSTIMULATORY COMPOSITIONS COMPRISING SOLUBLE PARASITE EXTRACTS AND CORRESPONDING USES

Also Published As

Publication number Publication date
IL59841A (en) 1983-10-31
AU531965B2 (en) 1983-09-15
IE49590B1 (en) 1985-10-30
GR68201B (Direct) 1981-11-10
EP0018579A3 (en) 1981-03-25
IL59841A0 (en) 1980-06-30
DE3064090D1 (en) 1983-08-18
AU5776480A (en) 1980-11-06
EP0018579B1 (en) 1983-07-13
IE800858L (en) 1980-10-30
EP0018579A2 (en) 1980-11-12
US4596707A (en) 1986-06-24

Similar Documents

Publication Publication Date Title
PT71169A (en) Process for preparing babesiosis antigen and vaccines and diagnostic reagents containing said antigen
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
CS526280A3 (en) Novel lipophilic muramyl peptides and process for preparing thereof
DE3171001D1 (en) Diagnostic reagents for immunological tests and a process for preparing the same
DE2963977D1 (en) Antigen preparation, process for producing it and pharmacological or dental preparations containing the antigen preparation or antibodies thereto
IL63907A0 (en) Diagnostic method and antibody probe for use therein
GB2041517B (en) Material and process for immunological assay
IL61904A0 (en) Novel synthetic vaccine and process for producing same
JPS5533686A (en) Method and implement for holding reagent for diagnosis
DE3071377D1 (en) A process for detecting the presence of an antigen in a specimen
IL59132A0 (en) Reagent for the determination of lipase and process for the preparation thereof
JPS5616416A (en) Immunizing serum globulin bend and its method
YU259782A (en) Process for obtaining new oxazolidone and thiazolidone
GB2053233B (en) Vaccinating cyclopeptidic antigenic fraction process for isolating it and vaccines containing it
DE3160264D1 (en) Process for isolating viral glycoproteic antigens, and its use in the preparation of vaccines
DE3376360D1 (en) Fucosyl antigens, a process for their preparation and antibodies for recognising them, a cancer diagnosing kit containing the fucosyl antigens and a method for determination of cancer associated carbohydrate linkages
GB2058063B (en) Process for the preparation of 2-mercaptoalkyl-sulphides and 2-mercaptoalkylethers
GB2048068B (en) Vaccines containing antigens from t cruzi organisms
EP0467972A4 (en) Rickettsial antigens for vaccination and diagnosis
IL59607A0 (en) Method and means for distinguishing gemstones
GB2055602B (en) Hydrotreating catalyst preparation and process
PT80233A (en) Process for preparing glycosidic linkage related antigen
DE3071384D1 (en) Method and reagent for blood typing and method for preparing this reagent
DE3067697D1 (en) 1-azolyl-1-halogen-alkan-2-ones and process for the preparation of 1-azolyl-1-phenoxy-alkan-2-ones
JPS5416422A (en) 11fluoromethyl substitutedd alkylamine and process for preparing same

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19961031